MELIFLA

Details for Australian Trade Mark No. 1224878 (hide)

Owner Bristol-Myers Squibb Company incorporated in the State

Convention US 19 September 2007 77/283026

Service Spruson & Ferguson

Various Convention priority claimed: 19 September 2007, United States of America, No. 77/283026 in respect of PHARMACEUTICAL PREPARATIONS FOR HUMAN USE.

Filing Date 15 February 2008

Classes

Class 5 Pharmaceutical preparations for human use, including pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Event Publications

13 March 2008 Application filed

13 March 2008 Application Accepted

10 July 2008 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1224879-LIFECARE PCA

1224877-KIDSPIRATION BASE TEN BLOCKS